Table S2. The HG-specific biological processes.
GOID | P values_adjusted | go_terms | Dataset | HG-specific |
---|---|---|---|---|
GO:0001525 | 1.264E-06 | Angiogenesis | ZB | PD |
GO:0036092 | 1.584E-05 | Phosphatidylinositol-3-phosphate biosynthetic process | MSKCC | PD |
GO:0006661 | 9.918E-05 | Phosphatidylinositol biosynthetic process | MSKCC | PD |
GO:0006650 | 0.0002442 | Glycerophospholipid metabolic process | ZB | PD |
GO:0036092 | 0.000248 | Phosphatidylinositol-3-phosphate biosynthetic process | ZB | PD |
GO:1902751 | 0.0002485 | Positive regulation of cell cycle G2/M phase transition | ZB | PD |
GO:0006650 | 0.0003463 | Glycerophospholipid metabolic process | MSKCC | PD |
GO:0006661 | 0.0007599 | Phosphatidylinositol biosynthetic process | ZB | PD |
GO:0006644 | 0.000767 | Phospholipid metabolic process | ZB | PD |
GO:0008584 | 0.0008151 | Male gonad development | MSKCC | PD |
GO:0046546 | 0.0008151 | Development of primary male sexual characteristics | MSKCC | PD |
GO:0006644 | 0.0010525 | Phospholipid metabolic process | MSKCC | PD |
GO:0046474 | 0.0010952 | Glycerophospholipid biosynthetic process | MSKCC | PD |
GO:0090218 | 0.0015026 | Positive regulation of lipid kinase activity | MSKCC | PD |
GO:0045017 | 0.0018219 | Glycerolipid biosynthetic process | MSKCC | PD |
GO:0019637 | 0.0019276 | Organophosphate metabolic process | ZB | PD |
GO:0007126 | 0.002289 | Meiotic nuclear division | ZB | PD |
GO:0008654 | 0.0023611 | Phospholipid biosynthetic process | MSKCC | PD |
GO:0043551 | 0.0026075 | Regulation of phosphatidylinositol 3-kinase activity | MSKCC | PD |
GO:1903046 | 0.0027839 | Meiotic cell cycle process | ZB | PD |
GO:1903727 | 0.0027864 | Positive regulation of phospholipid metabolic process | MSKCC | PD |
GO:0001525 | 0.0030352 | Angiogenesis | MSKCC | PD |
GO:0010518 | 0.0032304 | Positive regulation of phospholipase activity | ZB | PD |
GO:0030855 | 0.0040562 | Epithelial cell differentiation | MSKCC | PD |
GO:0035272 | 0.0042767 | Exocrine system development | MSKCC | PD |
GO:0043550 | 0.0042767 | Regulation of lipid kinase activity | MSKCC | PD |
GO:1902749 | 0.0046541 | Regulation of cell cycle G2/M phase transition | MSKCC | PD |
GO:0048146 | 0.0049414 | Positive regulation of fibroblast proliferation | MSKCC | PD |
GO:0033008 | 0.0050369 | Positive regulation of mast cell activation involved in immune response | ZB | PD |
GO:0043306 | 0.0050369 | Positive regulation of mast cell degranulation | ZB | PD |
GO:0046474 | 0.0050474 | Glycerophospholipid biosynthetic process | ZB | PD |
GO:0051321 | 0.0051928 | Meiotic cell cycle | ZB | PD |
GO:0043269 | 0.0052714 | Regulation of ion transport | MSKCC | PD |
GO:0014068 | 0.0059387 | Positive regulation of phosphatidylinositol 3-kinase signaling | ZB | PD |
GO:0033008 | 0.0062257 | Positive regulation of mast cell activation involved in immune response | MSKCC | PD |
GO:0043306 | 0.0062257 | Positive regulation of mast cell degranulation | MSKCC | PD |
GO:0033005 | 0.0066599 | Positive regulation of mast cell activation | ZB | PD |
GO:0045017 | 0.0071944 | Glycerolipid biosynthetic process | ZB | PD |
GO:0044839 | 0.0072853 | Cell cycle G2/M phase transition | MSKCC | PD |
GO:0014068 | 0.0073914 | Positive regulation of phosphatidylinositol 3-kinase signaling | MSKCC | PD |
GO:0002888 | 0.0080025 | Positive regulation of myeloid leukocyte mediated immunity | ZB | PD |
GO:0043302 | 0.0080025 | Positive regulation of leukocyte degranulation | ZB | PD |
GO:0033005 | 0.0082744 | Positive regulation of mast cell activation | MSKCC | PD |
GO:0008654 | 0.0087335 | Phospholipid biosynthetic process | ZB | PD |
GO:0034109 | 0.0088759 | Homotypic cell-cell adhesion | ZB | PD |
GO:0030855 | 0.0089828 | Epithelial cell differentiation | ZB | PD |
GO:1902751 | 0.0091779 | Positive regulation of cell cycle G2/M phase transition | MSKCC | PD |
GO:0006629 | 0.0093471 | Lipid metabolic process | MSKCC | PD |
GO:0008610 | 0.0100358 | Lipid biosynthetic process | MSKCC | PD |
GO:0002888 | 0.0100358 | Positive regulation of myeloid leukocyte mediated immunity | MSKCC | PD |
GO:0043302 | 0.0100358 | Positive regulation of leukocyte degranulation | MSKCC | PD |
GO:0034109 | 0.0114927 | Homotypic cell-cell adhesion | MSKCC | PD |
GO:0051656 | 0.0119185 | Establishment of organelle localization | ZB | PD |
GO:0043269 | 0.0125078 | Regulation of ion transport | ZB | PD |
GO:0060735 | 0.0129404 | Regulation of eif2 alpha phosphorylation by dsRNA | ZB | PD |
GO:0042102 | 0.0130323 | Positive regulation of T cell proliferation | ZB | PD |
GO:0030178 | 0.0141809 | Negative regulation of Wnt signaling pathway | ZB | PD |
GO:0006629 | 0.0150464 | Lipid metabolic process | ZB | PD |
GO:0051656 | 0.0165508 | Establishment of organelle localization | MSKCC | PD |
GO:0060735 | 0.0165508 | Regulation of eif2 alpha phosphorylation by dsRNA | MSKCC | PD |
GO:0007126 | 0.0170219 | Meiotic nuclear division | MSKCC | PD |
GO:0042102 | 0.0174305 | Positive regulation of T cell proliferation | MSKCC | PD |
GO:0090218 | 0.0181076 | Positive regulation of lipid kinase activity | ZB | PD |
GO:0032885 | 0.0187746 | Regulation of polysaccharide biosynthetic process | ZB | PD |
GO:0030178 | 0.0195602 | Negative regulation of Wnt signaling pathway | MSKCC | PD |
GO:1903046 | 0.0198476 | Meiotic cell cycle process | MSKCC | PD |
GO:0008610 | 0.020913 | Lipid biosynthetic process | ZB | PD |
GO:0032752 | 0.0213557 | Positive regulation of interleukin-3 production | ZB | PD |
GO:0042223 | 0.0213557 | Interleukin-3 biosynthetic process | ZB | PD |
GO:0043366 | 0.0213557 | Beta selection | ZB | PD |
GO:0045399 | 0.0213557 | Regulation of interleukin-3 biosynthetic process | ZB | PD |
GO:0045401 | 0.0213557 | Positive regulation of interleukin-3 biosynthetic process | ZB | PD |
GO:0007257 | 0.0216117 | Activation of JUN kinase activity | ZB | PD |
GO:0032881 | 0.0216117 | Regulation of polysaccharide metabolic process | ZB | PD |
GO:1902749 | 0.0218429 | Regulation of cell cycle G2/M phase transition | ZB | PD |
GO:0044839 | 0.0237717 | Cell cycle G2/M phase transition | ZB | PD |
GO:0033003 | 0.0243556 | Regulation of mast cell activation | ZB | PD |
GO:0043551 | 0.0243556 | Regulation of phosphatidylinositol 3-kinase activity | ZB | PD |
GO:1903727 | 0.0252945 | Positive regulation of phospholipid metabolic process | ZB | PD |
GO:0032885 | 0.0253146 | Regulation of polysaccharide biosynthetic process | MSKCC | PD |
GO:0009409 | 0.0262411 | Response to cold | ZB | PD |
GO:1903307 | 0.0262411 | Positive regulation of regulated secretory pathway | ZB | PD |
GO:0032752 | 0.0274151 | Positive regulation of interleukin-3 production | MSKCC | PD |
GO:0042223 | 0.0274151 | Interleukin-3 biosynthetic process | MSKCC | PD |
GO:0043366 | 0.0274151 | Beta selection | MSKCC | PD |
GO:0045399 | 0.0274151 | Regulation of interleukin-3 biosynthetic process | MSKCC | PD |
GO:0045401 | 0.0274151 | Positive regulation of interleukin-3 biosynthetic process | MSKCC | PD |
GO:0008584 | 0.0282742 | Male gonad development | ZB | PD |
GO:0046546 | 0.0282742 | Development of primary male sexual characteristics | ZB | PD |
GO:0002351 | 0.0282742 | Serotonin production involved in inflammatory response | ZB | PD |
GO:0002442 | 0.0282742 | Serotonin secretion involved in inflammatory response | ZB | PD |
GO:0002554 | 0.0282742 | Serotonin secretion by platelet | ZB | PD |
GO:0032252 | 0.0282742 | Secretory granule localization | ZB | PD |
GO:0032672 | 0.0282742 | Regulation of interleukin-3 production | ZB | PD |
GO:0045425 | 0.0282742 | Positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process | ZB | PD |
GO:0045588 | 0.0282742 | Positive regulation of gamma-delta T cell differentiation | ZB | PD |
GO:1901843 | 0.0282742 | Positive regulation of high voltage-gated calcium channel activity | ZB | PD |
GO:0007257 | 0.0285333 | Activation of JUN kinase activity | MSKCC | PD |
GO:0032881 | 0.0285333 | Regulation of polysaccharide metabolic process | MSKCC | PD |
GO:0042129 | 0.0307477 | Regulation of T cell proliferation | ZB | PD |
GO:0051321 | 0.0309104 | Meiotic cell cycle | MSKCC | PD |
GO:0035272 | 0.0318221 | Exocrine system development | ZB | PD |
GO:0043550 | 0.0318221 | Regulation of lipid kinase activity | ZB | PD |
GO:0033003 | 0.0322116 | Regulation of mast cell activation | MSKCC | PD |
GO:0048146 | 0.0343113 | Positive regulation of fibroblast proliferation | ZB | PD |
GO:0010897 | 0.0343113 | Negative regulation of triglyceride catabolic process | ZB | PD |
GO:0032632 | 0.0343113 | Interleukin-3 production | ZB | PD |
GO:0045423 | 0.0343113 | Regulation of granulocyte macrophage colony-stimulating factor biosynthetic process | ZB | PD |
GO:0060699 | 0.0343113 | Regulation of endoribonuclease activity | ZB | PD |
GO:0007405 | 0.0343407 | Neuroblast proliferation | ZB | PD |
GO:0009409 | 0.0344727 | Response to cold | MSKCC | PD |
GO:1903307 | 0.0344727 | Positive regulation of regulated secretory pathway | MSKCC | PD |
GO:0002351 | 0.0359801 | Serotonin production involved in inflammatory response | MSKCC | PD |
GO:0002442 | 0.0359801 | Serotonin secretion involved in inflammatory response | MSKCC | PD |
GO:0002554 | 0.0359801 | Serotonin secretion by platelet | MSKCC | PD |
GO:0032252 | 0.0359801 | Secretory granule localization | MSKCC | PD |
GO:0032672 | 0.0359801 | Regulation of interleukin-3 production | MSKCC | PD |
GO:0045425 | 0.0359801 | Positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process | MSKCC | PD |
GO:0045588 | 0.0359801 | Positive regulation of gamma-delta T cell differentiation | MSKCC | PD |
GO:1901843 | 0.0359801 | Positive regulation of high voltage-gated calcium channel activity | MSKCC | PD |
GO:0010518 | 0.040339 | Positive regulation of phospholipase activity | MSKCC | PD |
GO:0042129 | 0.0411271 | Regulation of T cell proliferation | MSKCC | PD |
GO:0010897 | 0.0437818 | Negative regulation of triglyceride catabolic process | MSKCC | PD |
GO:0032632 | 0.0437818 | Interleukin-3 production | MSKCC | PD |
GO:0045423 | 0.0437818 | Regulation of granulocyte macrophage colony-stimulating factor biosynthetic process | MSKCC | PD |
GO:0060699 | 0.0437818 | Regulation of endoribonuclease activity | MSKCC | PD |
GO:0007405 | 0.0450633 | Neuroblast proliferation | MSKCC | PD |
GO:0019637 | 0.045281 | Organophosphate metabolic process | MSKCC | PD |
GO:0042542 | 1.365E-07 | Response to hydrogen peroxide | MSKCC | MD |
GO:0014812 | 1.111E-06 | Muscle cell migration | MSKCC | MD |
GO:0042493 | 1.147E-06 | Response to drug | MSKCC | MD |
GO:1901652 | 1.569E-06 | Response to peptide | ZB | MD |
GO:0044092 | 1.981E-06 | Negative regulation of molecular function | ZB | MD |
GO:0043434 | 5.246E-06 | Response to peptide hormone | ZB | MD |
GO:0000302 | 1.172E-05 | Response to reactive oxygen species | MSKCC | MD |
GO:0034504 | 1.315E-05 | Protein localization to nucleus | MSKCC | MD |
GO:0033365 | 1.481E-05 | Protein localization to organelle | MSKCC | MD |
GO:0070301 | 2.532E-05 | Cellular response to hydrogen peroxide | MSKCC | MD |
GO:0009607 | 3.12E-05 | Response to biotic stimulus | MSKCC | MD |
GO:0034614 | 4.066E-05 | Cellular response to reactive oxygen species | MSKCC | MD |
GO:1904705 | 4.887E-05 | Regulation of vascular smooth muscle cell proliferation | MSKCC | MD |
GO:1990874 | 4.887E-05 | Vascular smooth muscle cell proliferation | MSKCC | MD |
GO:0003279 | 6.629E-05 | Cardiac septum development | MSKCC | MD |
GO:0051707 | 6.996E-05 | Response to other organism | MSKCC | MD |
GO:0043207 | 7.068E-05 | Response to external biotic stimulus | MSKCC | MD |
GO:1901652 | 7.61E-05 | Response to peptide | MSKCC | MD |
GO:0051223 | 9.568E-05 | Regulation of protein transport | MSKCC | MD |
GO:0060411 | 0.0001143 | Cardiac septum morphogenesis | MSKCC | MD |
GO:0014909 | 0.0001298 | Smooth muscle cell migration | MSKCC | MD |
GO:0032496 | 0.0001321 | Response to lipopolysaccharide | MSKCC | MD |
GO:0045682 | 0.0001383 | Regulation of epidermis development | MSKCC | MD |
GO:0006273 | 0.0001448 | Lagging strand elongation | MSKCC | MD |
GO:0043434 | 0.0001755 | Response to peptide hormone | MSKCC | MD |
GO:0002237 | 0.0001807 | Response to molecule of bacterial origin | MSKCC | MD |
GO:0003179 | 0.000188 | Heart valve morphogenesis | MSKCC | MD |
GO:0050864 | 0.0002231 | Regulation of B cell activation | MSKCC | MD |
GO:0003170 | 0.0002759 | Heart valve development | MSKCC | MD |
GO:0051570 | 0.0003745 | Regulation of histone H3-K9 methylation | ZB | MD |
GO:0044092 | 0.0004357 | Negative regulation of molecular function | MSKCC | MD |
GO:0042100 | 0.0004756 | B cell proliferation | MSKCC | MD |
GO:0000302 | 0.0005009 | Response to reactive oxygen species | ZB | MD |
GO:1904019 | 0.0005234 | Epithelial cell apoptotic process | MSKCC | MD |
GO:0006266 | 0.0005342 | DNA ligation | ZB | MD |
GO:0034614 | 0.00056 | Cellular response to reactive oxygen species | ZB | MD |
GO:2001242 | 0.0005685 | Regulation of intrinsic apoptotic signaling pathway | MSKCC | MD |
GO:0046879 | 0.0006353 | Hormone secretion | MSKCC | MD |
GO:0006271 | 0.0006777 | DNA strand elongation involved in DNA replication | MSKCC | MD |
GO:0003205 | 0.0007089 | Cardiac chamber development | MSKCC | MD |
GO:0003007 | 0.0007878 | Heart morphogenesis | MSKCC | MD |
GO:0009914 | 0.0008096 | Hormone transport | MSKCC | MD |
GO:0034504 | 0.0008947 | Protein localization to nucleus | ZB | MD |
GO:0051567 | 0.000944 | Histone H3-K9 methylation | ZB | MD |
GO:0030888 | 0.001 | Regulation of B cell proliferation | MSKCC | MD |
GO:0032611 | 0.001 | Interleukin-1 beta production | MSKCC | MD |
GO:0033157 | 0.001093 | Regulation of intracellular protein transport | ZB | MD |
GO:1902042 | 0.001286 | Negative regulation of extrinsic apoptotic signaling pathway via death domain receptors | ZB | MD |
GO:0050852 | 0.0012901 | T cell receptor signaling pathway | MSKCC | MD |
GO:0006266 | 0.0012907 | DNA ligation | MSKCC | MD |
GO:0032845 | 0.0013576 | Negative regulation of homeostatic process | MSKCC | MD |
GO:0003281 | 0.0014821 | Ventricular septum development | MSKCC | MD |
GO:0033143 | 0.0014821 | Regulation of intracellular steroid hormone receptor signaling pathway | MSKCC | MD |
GO:0022616 | 0.001571 | DNA strand elongation | MSKCC | MD |
GO:0071887 | 0.0016635 | Leukocyte apoptotic process | ZB | MD |
GO:1904035 | 0.0017433 | Regulation of epithelial cell apoptotic process | MSKCC | MD |
GO:0032612 | 0.0019145 | Interleukin-1 production | MSKCC | MD |
GO:0097306 | 0.0019363 | Cellular response to alcohol | ZB | MD |
GO:0034968 | 0.0021658 | Histone lysine methylation | ZB | MD |
GO:0061647 | 0.002279 | Histone H3-K9 modification | ZB | MD |
GO:0033146 | 0.002285 | Regulation of intracellular estrogen receptor signaling pathway | MSKCC | MD |
GO:0022408 | 0.0023527 | Negative regulation of cell-cell adhesion | MSKCC | MD |
GO:0033157 | 0.0023985 | Regulation of intracellular protein transport | MSKCC | MD |
GO:0051223 | 0.0024086 | Regulation of protein transport | ZB | MD |
GO:0032446 | 0.0024086 | Protein modification by small protein conjugation | ZB | MD |
GO:0051573 | 0.0028681 | Negative regulation of histone H3-K9 methylation | ZB | MD |
GO:0018022 | 0.0028725 | Peptidyl-lysine methylation | ZB | MD |
GO:0046824 | 0.0028725 | Positive regulation of nucleocytoplasmic transport | ZB | MD |
GO:0031648 | 0.0030756 | Protein destabilization | MSKCC | MD |
GO:0009636 | 0.0032692 | Response to toxic substance | ZB | MD |
GO:0006261 | 0.0033055 | DNA-dependent DNA replication | MSKCC | MD |
GO:0006273 | 0.0033374 | Lagging strand elongation | ZB | MD |
GO:0002223 | 0.0035118 | Stimulatory C-type lectin receptor signaling pathway | ZB | MD |
GO:0002220 | 0.0036986 | Innate immune response activating cell surface receptor signaling pathway | ZB | MD |
GO:0051103 | 0.0038896 | DNA ligation involved in DNA repair | ZB | MD |
GO:0003007 | 0.0040602 | Heart morphogenesis | ZB | MD |
GO:0016571 | 0.0042866 | Histone methylation | ZB | MD |
GO:0097306 | 0.0044943 | Cellular response to alcohol | MSKCC | MD |
GO:0031060 | 0.0045733 | Regulation of histone methylation | ZB | MD |
GO:0023061 | 0.0047426 | Signal release | MSKCC | MD |
GO:0051573 | 0.0047426 | Negative regulation of histone H3-K9 methylation | MSKCC | MD |
GO:0001666 | 0.0047462 | Response to hypoxia | MSKCC | MD |
GO:0006284 | 0.0050431 | Base-excision repair | MSKCC | MD |
GO:0018205 | 0.0051017 | Peptidyl-lysine modification | ZB | MD |
GO:0036293 | 0.0053204 | Response to decreased oxygen levels | MSKCC | MD |
GO:0061647 | 0.0053204 | Histone H3-K9 modification | MSKCC | MD |
GO:0006261 | 0.0055276 | DNA-dependent DNA replication | ZB | MD |
GO:2001020 | 0.0055567 | Regulation of response to DNA damage stimulus | MSKCC | MD |
GO:0032446 | 0.0057176 | Protein modification by small protein conjugation | MSKCC | MD |
GO:0014909 | 0.0058867 | Smooth muscle cell migration | ZB | MD |
GO:0070664 | 0.0058867 | Negative regulation of leukocyte proliferation | ZB | MD |
GO:0090316 | 0.0059508 | Positive regulation of intracellular protein transport | MSKCC | MD |
GO:0032651 | 0.0061433 | Regulation of interleukin-1 beta production | MSKCC | MD |
GO:0006304 | 0.0062479 | DNA modification | MSKCC | MD |
GO:0051103 | 0.0062941 | DNA ligation involved in DNA repair | MSKCC | MD |
GO:0030520 | 0.0064205 | Intracellular estrogen receptor signaling pathway | MSKCC | MD |
GO:0042093 | 0.0064205 | T-helper cell differentiation | MSKCC | MD |
GO:0045936 | 0.0065605 | Negative regulation of phosphate metabolic process | ZB | MD |
GO:0010563 | 0.0066057 | Negative regulation of phosphorus metabolic process | ZB | MD |
GO:0045604 | 0.0067768 | Regulation of epidermal cell differentiation | MSKCC | MD |
GO:0031061 | 0.0067822 | Negative regulation of histone methylation | ZB | MD |
GO:0034968 | 0.0067993 | Histone lysine methylation | MSKCC | MD |
GO:0002294 | 0.0071277 | CD4-positive, alpha-beta T cell differentiation involved in immune response | MSKCC | MD |
GO:0002287 | 0.0074349 | alpha-beta T cell activation involved in immune response | MSKCC | MD |
GO:0002293 | 0.0074349 | alpha-beta T cell differentiation involved in immune response | MSKCC | MD |
GO:0031663 | 0.0074349 | Lipopolysaccharide-mediated signaling pathway | MSKCC | MD |
GO:0038034 | 0.0077505 | Signal transduction in absence of ligand | ZB | MD |
GO:0097192 | 0.0077505 | Extrinsic apoptotic signaling pathway in absence of ligand | ZB | MD |
GO:0034284 | 0.0078981 | Response to monosaccharide | MSKCC | MD |
GO:0006271 | 0.0081662 | DNA strand elongation involved in DNA replication | ZB | MD |
GO:0046660 | 0.0082366 | Female sex differentiation | MSKCC | MD |
GO:0014812 | 0.008241 | Muscle cell migration | ZB | MD |
GO:0003283 | 0.0088126 | Atrial septum development | ZB | MD |
GO:0023019 | 0.0088126 | Signal transduction involved in regulation of gene expression | ZB | MD |
GO:0007259 | 0.0089793 | JAK-STAT cascade | ZB | MD |
GO:0097696 | 0.0089793 | STAT cascade | ZB | MD |
GO:0018022 | 0.0091089 | Peptidyl-lysine methylation | MSKCC | MD |
GO:0046824 | 0.0091089 | Positive regulation of nucleocytoplasmic transport | MSKCC | MD |
GO:0001541 | 0.0092698 | Ovarian follicle development | MSKCC | MD |
GO:0070301 | 0.0095041 | Cellular response to hydrogen peroxide | ZB | MD |
GO:0002292 | 0.0096977 | T cell differentiation involved in immune response | MSKCC | MD |
GO:1903533 | 0.0097929 | Regulation of protein targeting | ZB | MD |
GO:0006479 | 0.0099192 | Protein methylation | ZB | MD |
GO:0008213 | 0.0099192 | Protein alkylation | ZB | MD |
GO:0050852 | 0.0099192 | T cell receptor signaling pathway | ZB | MD |
GO:0032845 | 0.0101971 | Negative regulation of homeostatic process | ZB | MD |
GO:0031060 | 0.0104978 | Regulation of histone methylation | MSKCC | MD |
GO:0032652 | 0.0104978 | Regulation of interleukin-1 production | MSKCC | MD |
GO:0008625 | 0.0108141 | Extrinsic apoptotic signaling pathway via death domain receptors | ZB | MD |
GO:0032496 | 0.0108141 | Response to lipopolysaccharide | ZB | MD |
GO:0009743 | 0.0108748 | Response to carbohydrate | MSKCC | MD |
GO:0001947 | 0.0108748 | Heart looping | MSKCC | MD |
GO:0048678 | 0.0108748 | Response to axon injury | MSKCC | MD |
GO:0072091 | 0.0108748 | Regulation of stem cell proliferation | MSKCC | MD |
GO:1903533 | 0.0110206 | Regulation of protein targeting | MSKCC | MD |
GO:0002223 | 0.0110206 | Stimulatory C-type lectin receptor signaling pathway | MSKCC | MD |
GO:0031061 | 0.0110206 | Negative regulation of histone methylation | MSKCC | MD |
GO:0043367 | 0.0112179 | CD4-positive, alpha-beta T cell differentiation | MSKCC | MD |
GO:0002220 | 0.0115502 | Innate immune response activating cell surface receptor signaling pathway | MSKCC | MD |
GO:1904705 | 0.0117161 | Regulation of vascular smooth muscle cell proliferation | ZB | MD |
GO:1990874 | 0.0117161 | Vascular smooth muscle cell proliferation | ZB | MD |
GO:0042100 | 0.0117593 | B cell proliferation | ZB | MD |
GO:1904019 | 0.0124536 | Epithelial cell apoptotic process | ZB | MD |
GO:0006471 | 0.0125445 | Protein ADP-ribosylation | ZB | MD |
GO:0002237 | 0.0127762 | Response to molecule of bacterial origin | ZB | MD |
GO:0061371 | 0.0130477 | Determination of heart left/right asymmetry | MSKCC | MD |
GO:0016571 | 0.0132027 | Histone methylation | MSKCC | MD |
GO:0022616 | 0.0132769 | DNA strand elongation | ZB | MD |
GO:0008585 | 0.0132769 | Female gonad development | ZB | MD |
GO:0003143 | 0.0134719 | Embryonic heart tube morphogenesis | MSKCC | MD |
GO:0008589 | 0.0134719 | Regulation of smoothened signaling pathway | MSKCC | MD |
GO:0035710 | 0.0134719 | CD4-positive, alpha-beta T cell activation | MSKCC | MD |
GO:0070664 | 0.0134719 | Negative regulation of leukocyte proliferation | MSKCC | MD |
GO:0071301 | 0.0136096 | Cellular response to vitamin B1 | ZB | MD |
GO:0090347 | 0.0136096 | Regulation of cellular organohalogen metabolic process | ZB | MD |
GO:0090348 | 0.0136096 | Regulation of cellular organofluorine metabolic process | ZB | MD |
GO:0090349 | 0.0136096 | Negative regulation of cellular organohalogen metabolic process | ZB | MD |
GO:0090350 | 0.0136096 | Negative regulation of cellular organofluorine metabolic process | ZB | MD |
GO:1904404 | 0.0136096 | Response to formaldehyde | ZB | MD |
GO:0003279 | 0.0136766 | Cardiac septum development | ZB | MD |
GO:0046545 | 0.0139992 | Development of primary female sexual characteristics | ZB | MD |
GO:0009743 | 0.0140538 | Response to carbohydrate | ZB | MD |
GO:0043086 | 0.0143878 | Negative regulation of catalytic activity | ZB | MD |
GO:0003283 | 0.0143938 | Atrial septum development | MSKCC | MD |
GO:0023019 | 0.0143938 | Signal transduction involved in regulation of gene expression | MSKCC | MD |
GO:0007389 | 0.015078 | Pattern specification process | MSKCC | MD |
GO:0006304 | 0.0153019 | DNA modification | ZB | MD |
GO:0051100 | 0.0154442 | Negative regulation of binding | MSKCC | MD |
GO:0045936 | 0.0155204 | Negative regulation of phosphate metabolic process | MSKCC | MD |
GO:0051570 | 0.015525 | Regulation of histone H3-K9 methylation | MSKCC | MD |
GO:0010563 | 0.01554 | Negative regulation of phosphorus metabolic process | MSKCC | MD |
GO:0046634 | 0.0155981 | Regulation of alpha-beta T cell activation | MSKCC | MD |
GO:0071301 | 0.0155981 | Cellular response to vitamin B1 | MSKCC | MD |
GO:0090347 | 0.0155981 | Regulation of cellular organohalogen metabolic process | MSKCC | MD |
GO:0090348 | 0.0155981 | Regulation of cellular organofluorine metabolic process | MSKCC | MD |
GO:0090349 | 0.0155981 | Negative regulation of cellular organohalogen metabolic process | MSKCC | MD |
GO:0090350 | 0.0155981 | Negative regulation of cellular organofluorine metabolic process | MSKCC | MD |
GO:1904404 | 0.0155981 | Response to formaldehyde | MSKCC | MD |
GO:0033146 | 0.0159353 | Regulation of intracellular estrogen receptor signaling pathway | ZB | MD |
GO:0051051 | 0.0167241 | Negative regulation of transport | MSKCC | MD |
GO:0038034 | 0.0167508 | Signal transduction in absence of ligand | MSKCC | MD |
GO:0097192 | 0.0167508 | Extrinsic apoptotic signaling pathway in absence of ligand | MSKCC | MD |
GO:0046660 | 0.0191336 | Female sex differentiation | ZB | MD |
GO:0031648 | 0.01952 | Protein destabilization | ZB | MD |
GO:0006471 | 0.0196997 | Protein ADP-ribosylation | MSKCC | MD |
GO:0043086 | 0.0202833 | Negative regulation of catalytic activity | MSKCC | MD |
GO:0003179 | 0.0203264 | Heart valve morphogenesis | ZB | MD |
GO:0003230 | 0.0203264 | Cardiac atrium development | ZB | MD |
GO:0033365 | 0.0219486 | Protein localization to organelle | ZB | MD |
GO:0042542 | 0.0231473 | Response to hydrogen peroxide | ZB | MD |
GO:0010868 | 0.0231473 | Negative regulation of triglyceride biosynthetic process | ZB | MD |
GO:0071460 | 0.0231473 | Cellular response to cell-matrix adhesion | ZB | MD |
GO:0090345 | 0.0231473 | Cellular organohalogen metabolic process | ZB | MD |
GO:0090346 | 0.0231473 | Cellular organofluorine metabolic process | ZB | MD |
GO:0050864 | 0.0232449 | Regulation of B cell activation | ZB | MD |
GO:0044262 | 0.0234314 | Cellular carbohydrate metabolic process | MSKCC | MD |
GO:0003170 | 0.0234325 | Heart valve development | ZB | MD |
GO:0008625 | 0.0238195 | Extrinsic apoptotic signaling pathway via death domain receptors | MSKCC | MD |
GO:0043029 | 0.0244019 | T cell homeostasis | ZB | MD |
GO:0046825 | 0.0252439 | Regulation of protein export from nucleus | ZB | MD |
GO:0018205 | 0.0254654 | Peptidyl-lysine modification | MSKCC | MD |
GO:0090316 | 0.0255328 | Positive regulation of intracellular protein transport | ZB | MD |
GO:0022408 | 0.0260472 | Negative regulation of cell-cell adhesion | ZB | MD |
GO:0006284 | 0.0260472 | Base-excision repair | ZB | MD |
GO:0010883 | 0.0260472 | Regulation of lipid storage | ZB | MD |
GO:0007259 | 0.0262577 | JAK-STAT cascade | MSKCC | MD |
GO:0097696 | 0.0262577 | STAT cascade | MSKCC | MD |
GO:0051567 | 0.0262577 | Histone H3-K9 methylation | MSKCC | MD |
GO:0010868 | 0.0262577 | Negative regulation of triglyceride biosynthetic process | MSKCC | MD |
GO:0071460 | 0.0262577 | Cellular response to cell-matrix adhesion | MSKCC | MD |
GO:0090345 | 0.0262577 | Cellular organohalogen metabolic process | MSKCC | MD |
GO:0090346 | 0.0262577 | Cellular organofluorine metabolic process | MSKCC | MD |
GO:0044262 | 0.0265122 | Cellular carbohydrate metabolic process | ZB | MD |
GO:0042493 | 0.0271005 | Response to drug | ZB | MD |
GO:0006479 | 0.0275738 | Protein methylation | MSKCC | MD |
GO:0008213 | 0.0275738 | Protein alkylation | MSKCC | MD |
GO:0008585 | 0.0277022 | Female gonad development | MSKCC | MD |
GO:0051100 | 0.029382 | Negative regulation of binding | ZB | MD |
GO:0032651 | 0.0295013 | Regulation of interleukin-1 beta production | ZB | MD |
GO:0043525 | 0.0295013 | Positive regulation of neuron apoptotic process | ZB | MD |
GO:0051055 | 0.0295013 | Negative regulation of lipid biosynthetic process | ZB | MD |
GO:0007389 | 0.0295013 | Pattern specification process | ZB | MD |
GO:0023061 | 0.0295013 | Signal release | ZB | MD |
GO:0030520 | 0.0295013 | Intracellular estrogen receptor signaling pathway | ZB | MD |
GO:0042093 | 0.0295013 | T-helper cell differentiation | ZB | MD |
GO:0009822 | 0.0295013 | Alkaloid catabolic process | ZB | MD |
GO:0010266 | 0.0295013 | Response to vitamin B1 | ZB | MD |
GO:0033076 | 0.0295013 | Isoquinoline alkaloid metabolic process | ZB | MD |
GO:0071494 | 0.0295013 | Cellular response to UV-C | ZB | MD |
GO:0098760 | 0.0295013 | Response to interleukin-7 | ZB | MD |
GO:0098761 | 0.0295013 | Cellular response to interleukin-7 | ZB | MD |
GO:1990785 | 0.0295013 | Response to water-immersion restraint stress | ZB | MD |
GO:0071887 | 0.029714 | Leukocyte apoptotic process | MSKCC | MD |
GO:0045604 | 0.0298719 | Regulation of epidermal cell differentiation | ZB | MD |
GO:0046545 | 0.0305378 | Development of primary female sexual characteristics | MSKCC | MD |
GO:1902042 | 0.0306947 | Negative regulation of extrinsic apoptotic signaling pathway via death domain receptors | MSKCC | MD |
GO:0002294 | 0.0309829 | CD4-positive, alpha-beta T cell differentiation involved in immune response | ZB | MD |
GO:0002287 | 0.0320739 | alpha-beta T cell activation involved in immune response | ZB | MD |
GO:0002293 | 0.0320739 | alpha-beta T cell differentiation involved in immune response | ZB | MD |
GO:0031663 | 0.0320739 | Lipopolysaccharide-mediated signaling pathway | ZB | MD |
GO:0003230 | 0.0321242 | Cardiac atrium development | MSKCC | MD |
GO:2001242 | 0.0323501 | Regulation of intrinsic apoptotic signaling pathway | ZB | MD |
GO:0051051 | 0.0324454 | Negative regulation of transport | ZB | MD |
GO:0051707 | 0.0338559 | Response to other organism | ZB | MD |
GO:0043207 | 0.033997 | Response to external biotic stimulus | ZB | MD |
GO:0009822 | 0.0354738 | Alkaloid catabolic process | MSKCC | MD |
GO:0010266 | 0.0354738 | Response to vitamin B1 | MSKCC | MD |
GO:0033076 | 0.0354738 | Isoquinoline alkaloid metabolic process | MSKCC | MD |
GO:0071494 | 0.0354738 | Cellular response to UV-C | MSKCC | MD |
GO:0098760 | 0.0354738 | Response to interleukin-7 | MSKCC | MD |
GO:0098761 | 0.0354738 | Cellular response to interleukin-7 | MSKCC | MD |
GO:1990785 | 0.0354738 | Response to water-immersion restraint stress | MSKCC | MD |
GO:0003205 | 0.0358613 | Cardiac chamber development | ZB | MD |
GO:0001541 | 0.0363016 | Ovarian follicle development | ZB | MD |
GO:0007089 | 0.0363016 | Traversing start control point of mitotic cell cycle | ZB | MD |
GO:0010989 | 0.0363016 | Negative regulation of low-density lipoprotein particle clearance | ZB | MD |
GO:0014042 | 0.0363016 | Positive regulation of neuron maturation | ZB | MD |
GO:0035799 | 0.0363016 | Ureter maturation | ZB | MD |
GO:0042997 | 0.0363016 | Negative regulation of Golgi to plasma membrane protein transport | ZB | MD |
GO:0070427 | 0.0363016 | Nucleotide-binding oligomerization domain containing 1 signaling pathway | ZB | MD |
GO:2000048 | 0.0363016 | Negative regulation of cell-cell adhesion mediated by cadherin | ZB | MD |
GO:0046879 | 0.0364954 | Hormone secretion | ZB | MD |
GO:0002292 | 0.0371894 | T cell differentiation involved in immune response | ZB | MD |
GO:0030888 | 0.0371894 | Regulation of B cell proliferation | ZB | MD |
GO:0032611 | 0.0371894 | Interleukin-1 beta production | ZB | MD |
GO:0043029 | 0.0386747 | T cell homeostasis | MSKCC | MD |
GO:0032652 | 0.0392552 | Regulation of interleukin-1 production | ZB | MD |
GO:2001020 | 0.039929 | Regulation of response to DNA damage stimulus | ZB | MD |
GO:0046825 | 0.0400926 | Regulation of protein export from nucleus | MSKCC | MD |
GO:0001947 | 0.040316 | Heart looping | ZB | MD |
GO:0048678 | 0.040316 | Response to axon injury | ZB | MD |
GO:0072091 | 0.040316 | Regulation of stem cell proliferation | ZB | MD |
GO:0009914 | 0.0407189 | Hormone transport | ZB | MD |
GO:0009607 | 0.0410816 | Response to biotic stimulus | ZB | MD |
GO:0043367 | 0.0414048 | CD4-positive, alpha-beta T cell differentiation | ZB | MD |
GO:0010883 | 0.0416577 | Regulation of lipid storage | MSKCC | MD |
GO:0007089 | 0.0432135 | Traversing start control point of mitotic cell cycle | MSKCC | MD |
GO:0010989 | 0.0432135 | Negative regulation of low-density lipoprotein particle clearance | MSKCC | MD |
GO:0014042 | 0.0432135 | Positive regulation of neuron maturation | MSKCC | MD |
GO:0035799 | 0.0432135 | Ureter maturation | MSKCC | MD |
GO:0042997 | 0.0432135 | Negative regulation of Golgi to plasma membrane protein transport | MSKCC | MD |
GO:0070427 | 0.0432135 | Nucleotide-binding oligomerization domain containing 1 signaling pathway | MSKCC | MD |
GO:2000048 | 0.0432135 | Negative regulation of cell-cell adhesion mediated by cadherin | MSKCC | MD |
GO:0003281 | 0.0437357 | Ventricular septum development | ZB | MD |
GO:0033143 | 0.0437357 | Regulation of intracellular steroid hormone receptor signaling pathway | ZB | MD |
GO:0060411 | 0.0437357 | Cardiac septum morphogenesis | ZB | MD |
GO:0061371 | 0.0447239 | Determination of heart left/right asymmetry | ZB | MD |
GO:0009636 | 0.0455879 | Response to toxic substance | MSKCC | MD |
GO:0003143 | 0.0456721 | Embryonic heart tube morphogenesis | ZB | MD |
GO:0008589 | 0.0456721 | Regulation of smoothened signaling pathway | ZB | MD |
GO:0035710 | 0.0456721 | CD4-positive, alpha-beta T cell activation | ZB | MD |
GO:0001666 | 0.0462698 | Response to hypoxia | ZB | MD |
GO:0043525 | 0.0463606 | Positive regulation of neuron apoptotic process | MSKCC | MD |
GO:0051055 | 0.0463606 | Negative regulation of lipid biosynthetic process | MSKCC | MD |
GO:0045682 | 0.0465784 | Regulation of epidermis development | ZB | MD |
GO:1904035 | 0.0465784 | Regulation of epithelial cell apoptotic process | ZB | MD |
GO:0034284 | 0.0473956 | Response to monosaccharide | ZB | MD |
GO:0032612 | 0.0473956 | Interleukin-1 production | ZB | MD |
GO:0036293 | 0.047653 | Response to decreased oxygen levels | ZB | MD |
GO:0046634 | 0.0493719 | Regulation of alpha-beta T cell activation | ZB | MD |
GO:1905005 | 0.0303648 | Regulation of epithelial to mesenchymal transition involved in endocardial cushion formation | ZB | WD |
GO:0003198 | 0.0462411 | Epithelial to mesenchymal transition involved in endocardial cushion formation | ZB | WD |
GO:0034110 | 0.0498585 | Regulation of homotypic cell-cell adhesion | ZB | WD |
GO:1905005 | 0.027475 | Regulation of epithelial to mesenchymal transition involved in endocardial cushion formation | MSKCC | WD |
GO:0003198 | 0.0414965 | Epithelial to mesenchymal transition involved in endocardial cushion formation | MSKCC | WD |
GO:0034110 | 0.0441837 | Regulation of homotypic cell-cell adhesion | MSKCC | WD |
Note: dataset, our dataset was named ZB. PD, poor differentiated; MD, moderate differentiated; WD, well differentiated.